Vancouver-based 1933 Industries Inc. has unveiled its financial results for the fourth quarter and full year ending July 31, 2024, demonstrating remarkable growth and enhanced financial health. The company has reported record revenues of $19.3 million for Fiscal 2024, reflecting a 15% increase compared to the previous year.
1933 Industries recorded a gross profit of $2.9 million, a notable recovery from a gross loss of $1.4 million in Fiscal 2023. This improvement corresponds with an increased gross margin, which rose to 15% from a negative margin of 8% in the prior year, indicating more effective management of production costs.
The company also reported a reduced net loss of $0.6 million for Fiscal 2024, down dramatically from a net loss of $14.6 million the previous year. This turnaround highlights the effectiveness of the company's strategic efforts to enhance operational efficiencies.
1933 Industries attributes its financial success to a disciplined operational approach and the strength of its Alternative Medicine Association (AMA) brand, which is a leading player in the Nevada cannabis market. AMA products have been recognized as top sellers, reinforcing the company's market presence.
As part of its operational strategy, the company decided to discontinue its Canna Hemp™ subsidiary due to unfavorable market conditions, a move aimed at refocusing its resources on more profitable ventures.
Looking ahead, 1933 Industries is set to release its first-quarter financial results for 2025 within the next five business days, allowing investors to gain further insights into its ongoing performance and market strategies.
1933 Industries reported record revenues of CAD 19.3 million for Fiscal 2024, marking a 15% increase year-over-year. This impressive performance was complemented by a gross profit of CAD 2.9 million, a significant turnaround from a loss of CAD 1.4 million in the previous fiscal year.
The company achieved a gross profit of CAD 2.9 million in Fiscal 2024, highlighting a strong rebound from the prior year's loss. The gross margin increased to 15% in 2024, indicating improved cost management and operational efficiency.
1933 Industries implemented a disciplined approach to optimise operations and reduce production costs, which contributed to their record revenues and reduced net losses. This strategic focus reflects the company's commitment to enhancing profitability while maintaining product quality.
The net loss for 1933 Industries was reduced to CAD 0.6 million in Fiscal 2024, significantly down from CAD 14.6 million in the previous year. This substantial improvement illustrates the effectiveness of their operational strategies.
The company made the decision to discontinue its Canna Hemp™ CBD subsidiary due to the declining market, allowing them to focus on more viable operations. This strategic adjustment is expected to strengthen the company's overall market position.
The company’s AMA brand was recognised as a top-selling cannabis brand in Nevada for 2024, demonstrating strong consumer demand and brand loyalty, which bodes well for future growth.
1933 Industries is set to release its first quarter 2025 financial results within five business days of this report, providing investors with timely insights into the company's ongoing performance and strategic direction.
Comprehensive financial statements and management discussions are available on the company’s investor relations website and also on SEDAR, ensuring transparency and access to essential financial data.